FreeStride Therapeutics' Debt Round

FreeStride Therapeutics raised a round of funding on September 23, 2009. Investors include Michigan Pre-Seed Capital Fund.

FreeStride Therapeutics is developing and marketing a veterinary drug to address bone and inflammation problems, resulting in lameness and/or inability to perform, in horses and dogs primarily.…

Articles about FreeStride Therapeutics' Debt Round: